ArticleFrontiers in microbiology2026
Dual-probe genome mining identifies citrulassin N, a novel citrulline modified lasso peptide from
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis of β-Thiolated Amino Acids: Investigation Toward the Total Chemical Synthesis of Lasso Peptide Microcin J25.Chembiochem : a European journal of chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lasso peptides are a structurally distinctive class of ribosomally synthesized and post-translationally modified peptides (RiPPs) featuring a threaded rotaxane topology that confers remarkable thermal stability and protease resistance. Citrulassins represent a rare subgroup of lasso peptides distinguished by a citrulline residue generated through peptidylarginine deiminase (PAD)-catalyzed deimination of arginine. Prior to the identification of citrulassin A, such a modification had not been observed in RiPPs, and notably, the PAD-encoding gene is located outside the canonical lasso peptide biosynthetic gene cluster (BGC). Methods: Here, we developed a dual-probe genome-mining strategy that integrates homology searches for both the lasso peptide cyclase (CitC) and a PAD homolog to selectively prioritize candidate producers from the IFB bacterial genome database. Guided by this strategy, fermentation and targeted isolation led to the discovery of citrulassin N (1) from Results: Comprehensive structural elucidation using NMR spectroscopy and tandem mass spectrometry confirmed citrulassin N as a novel citrulline-modified lasso peptid. Discussion: This study expands the structural diversity of citrulline-containing lasso peptides, demonstrates the utility of a dual-probe genome-mining approach for identifying RiPPs with rare post-translational modifications, and provides a practical framework for the targeted discovery of functionally decorated RiPP natural products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.